D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
JANX holding history
Janux Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
JANX overviewAll 13F holders of JANXFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,096,509
- Value
- $16.8M
- % of portfolio
- <0.1%
- Quarters held
- 9
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,096,509 | $16.8M | <0.1% | +998,114+1,014.4% | Added | Holders |
| Q1 2026 | 98,395 | $1.37M | <0.1% | +65,688+200.8% | Added | Holders |
| Q4 2025 | 32,707 | $451.4K | <0.1% | +32,707 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −83,989−100.0% | Sold out | Holders |
| Q3 2024 | 83,989 | $3.82M | <0.1% | −13,834−14.1% | Reduced | Holders |
| Q2 2024 | 97,823 | $4.10M | <0.1% | +43,185+79.0% | Added | Holders |
| Q1 2024 | 54,638 | $2.06M | <0.1% | +54,638 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −11,480−100.0% | Sold out | Holders |
| Q1 2022 | 11,480 | $165.0K | <0.1% | −16,291−58.7% | Reduced | Holders |
| Q4 2021 | 27,771 | $548.0K | <0.1% | −18,385−39.8% | Reduced | Holders |
| Q3 2021 | 46,156 | $998.0K | <0.1% | +46,156 | New | Holders |